Literature DB >> 16047384

Proteomic comparison of two fractions derived from the transsynaptic scaffold.

Greg R Phillips1, Laurence Florens, Hidekazu Tanaka, Zin Z Khaing, Lazar Fidler, John R Yates, David R Colman.   

Abstract

A fraction derived from presynaptic specializations (presynaptic particle fraction; PPF) can be separated from postsynaptic densities (PSD) by adjusting the pH of Triton X-100 (TX-100) extraction of isolated transsynaptic scaffolds. Solubilization of the PPF corresponds to disruption of the presynaptic specialization. We show that the PPF is insoluble to repeated TX-100 extraction at pH 6.0 but becomes soluble in detergent at pH 8.0. By immunolocalization, we find that the major proteins of the PPF, clathrin and dynamin, are concentrated in the presynaptic compartment. By using multidimensional protein identification technology, we compared the protein compositions of the PPF and the PSD fraction. We identified a total of 341 proteins, 50 of which were uniquely found in the PPF, 231 in the PSD fraction, and 60 in both fractions. Comparison of the two fractions revealed a relatively low proportion of actin and associated proteins and a high proportion of vesicle or intracellular compartment proteins in the PPF. We conclude that the PPF consists of presynaptic proteins not connected to the actin-based synaptic framework; its insolubility in pH 6 and solubility in pH 8 buffered detergent suggests that clathrin might be an anchorage scaffold for many proteins in the PPF. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16047384     DOI: 10.1002/jnr.20614

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  24 in total

Review 1.  Proteomic analysis of the presynaptic active zone.

Authors:  W Volknandt; M Karas
Journal:  Exp Brain Res       Date:  2012-02-22       Impact factor: 1.972

Review 2.  Synaptosome proteomics.

Authors:  Fengju Bai; Frank A Witzmann
Journal:  Subcell Biochem       Date:  2007

Review 3.  Recent advances in neuroproteomics.

Authors:  Erika C Andrade; Dilja D Krueger; Angus C Nairn
Journal:  Curr Opin Mol Ther       Date:  2007-06

4.  Maximizing peptide identification events in proteomic workflows using data-dependent acquisition (DDA).

Authors:  Nicholas W Bateman; Scott P Goulding; Nicholas J Shulman; Avinash K Gadok; Karen K Szumlinski; Michael J MacCoss; Christine C Wu
Journal:  Mol Cell Proteomics       Date:  2013-07-02       Impact factor: 5.911

5.  Systems approach to explore components and interactions in the presynapse.

Authors:  Noura S Abul-Husn; Ittai Bushlin; José A Morón; Sherry L Jenkins; Georgia Dolios; Rong Wang; Ravi Iyengar; Avi Ma'ayan; Lakshmi A Devi
Journal:  Proteomics       Date:  2009-06       Impact factor: 3.984

6.  A mass spectrometry-based proteomic analysis of Homer2-interacting proteins in the mouse brain.

Authors:  Scott P Goulding; Karen K Szumlinski; Candice Contet; Michael J MacCoss; Christine C Wu
Journal:  J Proteomics       Date:  2017-07-17       Impact factor: 4.044

Review 7.  An integrated quantitative proteomics and systems biology approach to explore synaptic protein profile changes during morphine exposure.

Authors:  Steven D Stockton; Lakshmi A Devi
Journal:  Neuropsychopharmacology       Date:  2013-09-18       Impact factor: 7.853

8.  Quantitative neuroproteomics of the synapse.

Authors:  Dinah Lee Ramos-Ortolaza; Ittai Bushlin; Noura Abul-Husn; Suresh P Annangudi; Jonathan Sweedler; Lakshmi A Devi
Journal:  Methods Mol Biol       Date:  2010

9.  The organization of the transcriptional network in specific neuronal classes.

Authors:  Kellen D Winden; Michael C Oldham; Karoly Mirnics; Philip J Ebert; Christo H Swan; Pat Levitt; John L Rubenstein; Steve Horvath; Daniel H Geschwind
Journal:  Mol Syst Biol       Date:  2009-07-28       Impact factor: 11.429

10.  The post-synaptic density of human postmortem brain tissues: an experimental study paradigm for neuropsychiatric illnesses.

Authors:  Chang-Gyu Hahn; Anamika Banerjee; Matthew L Macdonald; Dan-Sung Cho; Joshua Kamins; Zhiping Nie; Karin E Borgmann-Winter; Tilo Grosser; Angel Pizarro; Eugene Ciccimaro; Steven E Arnold; Hoau-Yan Wang; Ian A Blair
Journal:  PLoS One       Date:  2009-04-16       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.